Aadi Bioscience (AADI) Revenue & Revenue Breakdown
Aadi Bioscience Revenue Highlights
Latest Revenue (Y)
$24.35M
Latest Revenue (Q)
$6.18M
Main Segment (Y)
Product
Aadi Bioscience Revenue by Period
Aadi Bioscience Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $24.35M | 60.06% |
| 2022-12-31 | $15.22M | 1421.60% |
| 2021-12-31 | $1.00M | -92.86% |
| 2020-12-31 | $14.00M | 1769.16% |
| 2019-12-31 | $749.00K | -96.28% |
| 2018-12-31 | $20.16M | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | - |
Aadi Bioscience generated $24.35M in revenue during NA 2023, up 60.06% compared to the previous quarter, and up 120.82% compared to the same period a year ago.
Aadi Bioscience Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $6.18M | 15.43% |
| 2024-03-31 | $5.35M | -15.38% |
| 2023-12-31 | $6.33M | 6.16% |
| 2023-09-30 | $5.96M | -3.92% |
| 2023-06-30 | $6.20M | 5.71% |
| 2023-03-31 | $5.87M | 12.24% |
| 2022-12-31 | $5.23M | 23.13% |
| 2022-09-30 | $4.25M | 23.51% |
| 2022-06-30 | $3.44M | 48.98% |
| 2022-03-31 | $2.31M | 130.70% |
| 2021-12-31 | $1.00M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $120.00K | -99.14% |
| 2020-12-31 | $14.00M | 5960.61% |
| 2020-09-30 | $231.00K | 158.43% |
| 2020-06-30 | $89.39K | -19.15% |
| 2020-03-31 | $110.56K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $2.14K | -99.99% |
| 2018-09-30 | $18.82M | 1311.65% |
| 2018-06-30 | $1.33M | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | - |
Aadi Bioscience generated $6.18M in revenue during Q2 2024, up 15.43% compared to the previous quarter, and up 105.32% compared to the same period a year ago.
Aadi Bioscience Revenue Breakdown
Aadi Bioscience Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Product | $24.35M | $15.22M | - | - | - |
| Grant | - | - | $120.00K | - | - |
| License | - | - | $1.00M | $20.00M | $20.00M |
Aadi Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $5.35M | $6.33M | $5.96M | $6.20M | $5.87M | $5.23M | $4.25M | $3.44M | $2.31M | - | - | - |
| Grant | - | - | - | - | - | - | - | - | $120.00K | - | - | - |
| License | - | - | - | - | - | - | - | - | - | - | $18.70M | $1.30M |
Aadi Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).
Aadi Bioscience Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical | $434.25M | $147.03M |
| ARVN | Arvinas | $78.50M | $76.50M |
| AADI | Aadi Bioscience | $24.35M | $6.18M |
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $10.97M |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| DSGN | Design Therapeutics | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| GRCL | Gracell Bio | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| KURA | Kura Oncology | - | - |
| ERAS | Erasca | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
AADI Revenue FAQ
What is Aadi Bioscience’s yearly revenue?
Aadi Bioscience's yearly revenue for 2023 was $24.35M, representing an increase of 60.06% compared to 2022. The company's yearly revenue for 2022 was $15.22M, representing an increase of 1421.60% compared to 2021. AADI's yearly revenue for 2021 was $1M, representing a decrease of -92.86% compared to 2020.
What is Aadi Bioscience’s quarterly revenue?
Aadi Bioscience's quarterly revenue for Q2 2024 was $6.18M, a 15.43% increase from the previous quarter (Q1 2024), and a -0.37% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $5.35M, a -15.38% decrease from the previous quarter (Q4 2023), and a -8.76% decrease year-over-year (Q1 2023). AADI's quarterly revenue for Q4 2023 was $6.33M, a 6.16% increase from the previous quarter (Q3 2023), and a 21.03% increase year-over-year (Q4 2022).
What is Aadi Bioscience’s revenue growth rate?
Aadi Bioscience's revenue growth rate for the last 3 years (2021-2023) was 2335.40%, and for the last 5 years (2019-2023) was 3151.54%.
What are Aadi Bioscience’s revenue streams?
Aadi Bioscience's revenue streams in c 23 are Product
What is Aadi Bioscience’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Aadi Bioscience was Product. This segment made a revenue of $24.35M, representing 100.00% of the company's total revenue.